Potential Efficacy of Janus Kinase Inhibitors in the Treatment of a Patient With Coexisting Peripheral and Axial Spondyloarthritis and Ulcerative Colitis.

IF 3.6 2区医学 Q2 RHEUMATOLOGY

Journal of Rheumatology Pub Date : 2024-11-01 DOI:10.3899/jrheum.2024-0055

Sho Ishigaki, Nobuhiko Kajio, Noritada Yoshikawa, Hiroaki Taguchi

引用次数: 0

查看原文本刊更多论文

Janus 激酶抑制剂在治疗并存外周和轴性脊柱关节炎及溃疡性结肠炎患者中的潜在疗效。

1 虽然 Janus 激酶抑制剂（JAKi）在治疗 UC 和银屑病关节炎方面显示出了疗效，但目前还没有用 JAKi 单药治疗 SpA 和 UC 并发症的报道。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Rheumatology 医学-风湿病学

CiteScore

6.50

自引率

5.10%

发文量

285

审稿时长

1 months

期刊介绍： The Journal of Rheumatology is a monthly international serial edited by Earl D. Silverman. The Journal features research articles on clinical subjects from scientists working in rheumatology and related fields, as well as proceedings of meetings as supplements to regular issues. Highlights of our 41 years serving Rheumatology include: groundbreaking and provocative editorials such as "Inverting the Pyramid," renowned Pediatric Rheumatology, proceedings of OMERACT and the Canadian Rheumatology Association, Cochrane Musculoskeletal Reviews, and supplements on emerging therapies.